HELIСOBACTER PYLORI-ASSOCIATED GASTRIC ULCER DISEASE: CLINICO-IMMUNOLOGI-CAL EFFECTIVENESS OF TREATMENT WITHOUT ANTIBIOTICS

Abstract. Most data of Heliсobacter pylori (HP) lifelong persistence in gastric mucosa and the intimate mechanisms of resistance to this infection are based only on phenomenological findings, such as absence or low HP colonization in mice and men spontaneously producing high levels of IL-2. 108 pati...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	T. A. Smirnova, O. V. Borovikov, E. P. Ponomarjova, R. A. Khanferjan
Formato:	article
Lenguaje:	RU
Publicado:	SPb RAACI 2014
Materias:	heliсobacter pylori gastric ulcer disease il–2 Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/c0de9ce4f38d4d35926ac3d3fc6616db
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:c0de9ce4f38d4d35926ac3d3fc6616db
record_format	dspace
spelling	oai:doaj.org-article:c0de9ce4f38d4d35926ac3d3fc6616db2021-11-18T08:03:42ZHELIСOBACTER PYLORI-ASSOCIATED GASTRIC ULCER DISEASE: CLINICO-IMMUNOLOGI-CAL EFFECTIVENESS OF TREATMENT WITHOUT ANTIBIOTICS1563-06252313-741X10.15789/1563-0625-2005-4-397-404https://doaj.org/article/c0de9ce4f38d4d35926ac3d3fc6616db2014-07-01T00:00:00Zhttps://www.mimmun.ru/mimmun/article/view/494https://doaj.org/toc/1563-0625https://doaj.org/toc/2313-741XAbstract. Most data of Heliсobacter pylori (HP) lifelong persistence in gastric mucosa and the intimate mechanisms of resistance to this infection are based only on phenomenological findings, such as absence or low HP colonization in mice and men spontaneously producing high levels of IL-2. 108 patients suffering from HP-associated gastric ulcer disease were randomly divided into two groups. The I group of patients was cured with standard three or four component methods of therapy included of two antibiotics (usually Klaritromycin and Amoxicillin), proton pomp inhibitors and H2 receptor antagonists. Patients of the second group were treated with the same therapy, but instead of antibiotics they received 0,1 mg rIL-2 - Roncoleukin dissolved in 2 ml 0,9% NaCl into four - six points аround gastric ulcer submucously using gastroscope techniques and 0,4 mg was dissolved in 400 ml 0,9% NaCl with 4 ml 10% human albumin and infused intravenously. This procedure was performed three times with the interval of 72 hours. Immunotherapy results in increase of CD25+, HLA-DR+ and CD16+CD56+ cells levels and the increase of the serum concentrations of IL-1б (3 folds), IL-6 (4 folds) and IFNг (more than 20 folds). One month after the end of treatment it was found that in the group treated with rIL-2 the HP eradication achieved in 95,4% in comparison to 81,5% in control patients. In Roncoleukin treated group ulcer epithelization period was 10,79±0,46 days and in traditionally treated group - 35,23±1,58 days.T. A. SmirnovaO. V. BorovikovE. P. PonomarjovaR. A. KhanferjanSPb RAACIarticleheliсobacter pylorigastric ulcer diseaseil–2Immunologic diseases. AllergyRC581-607RUMedicinskaâ Immunologiâ, Vol 7, Iss 4, Pp 397-404 (2014)
institution	DOAJ
collection	DOAJ
language	RU
topic	heliсobacter pylori gastric ulcer disease il–2 Immunologic diseases. Allergy RC581-607
spellingShingle	heliсobacter pylori gastric ulcer disease il–2 Immunologic diseases. Allergy RC581-607 T. A. Smirnova O. V. Borovikov E. P. Ponomarjova R. A. Khanferjan HELIСOBACTER PYLORI-ASSOCIATED GASTRIC ULCER DISEASE: CLINICO-IMMUNOLOGI-CAL EFFECTIVENESS OF TREATMENT WITHOUT ANTIBIOTICS
description	Abstract. Most data of Heliсobacter pylori (HP) lifelong persistence in gastric mucosa and the intimate mechanisms of resistance to this infection are based only on phenomenological findings, such as absence or low HP colonization in mice and men spontaneously producing high levels of IL-2. 108 patients suffering from HP-associated gastric ulcer disease were randomly divided into two groups. The I group of patients was cured with standard three or four component methods of therapy included of two antibiotics (usually Klaritromycin and Amoxicillin), proton pomp inhibitors and H2 receptor antagonists. Patients of the second group were treated with the same therapy, but instead of antibiotics they received 0,1 mg rIL-2 - Roncoleukin dissolved in 2 ml 0,9% NaCl into four - six points аround gastric ulcer submucously using gastroscope techniques and 0,4 mg was dissolved in 400 ml 0,9% NaCl with 4 ml 10% human albumin and infused intravenously. This procedure was performed three times with the interval of 72 hours. Immunotherapy results in increase of CD25+, HLA-DR+ and CD16+CD56+ cells levels and the increase of the serum concentrations of IL-1б (3 folds), IL-6 (4 folds) and IFNг (more than 20 folds). One month after the end of treatment it was found that in the group treated with rIL-2 the HP eradication achieved in 95,4% in comparison to 81,5% in control patients. In Roncoleukin treated group ulcer epithelization period was 10,79±0,46 days and in traditionally treated group - 35,23±1,58 days.
format	article
author	T. A. Smirnova O. V. Borovikov E. P. Ponomarjova R. A. Khanferjan
author_facet	T. A. Smirnova O. V. Borovikov E. P. Ponomarjova R. A. Khanferjan
author_sort	T. A. Smirnova
title	HELIСOBACTER PYLORI-ASSOCIATED GASTRIC ULCER DISEASE: CLINICO-IMMUNOLOGI-CAL EFFECTIVENESS OF TREATMENT WITHOUT ANTIBIOTICS
title_short	HELIСOBACTER PYLORI-ASSOCIATED GASTRIC ULCER DISEASE: CLINICO-IMMUNOLOGI-CAL EFFECTIVENESS OF TREATMENT WITHOUT ANTIBIOTICS
title_full	HELIСOBACTER PYLORI-ASSOCIATED GASTRIC ULCER DISEASE: CLINICO-IMMUNOLOGI-CAL EFFECTIVENESS OF TREATMENT WITHOUT ANTIBIOTICS
title_fullStr	HELIСOBACTER PYLORI-ASSOCIATED GASTRIC ULCER DISEASE: CLINICO-IMMUNOLOGI-CAL EFFECTIVENESS OF TREATMENT WITHOUT ANTIBIOTICS
title_full_unstemmed	HELIСOBACTER PYLORI-ASSOCIATED GASTRIC ULCER DISEASE: CLINICO-IMMUNOLOGI-CAL EFFECTIVENESS OF TREATMENT WITHOUT ANTIBIOTICS
title_sort	heliсobacter pylori-associated gastric ulcer disease: clinico-immunologi-cal effectiveness of treatment without antibiotics
publisher	SPb RAACI
publishDate	2014
url	https://doaj.org/article/c0de9ce4f38d4d35926ac3d3fc6616db
work_keys_str_mv	AT tasmirnova helisobacterpyloriassociatedgastriculcerdiseaseclinicoimmunologicaleffectivenessoftreatmentwithoutantibiotics AT ovborovikov helisobacterpyloriassociatedgastriculcerdiseaseclinicoimmunologicaleffectivenessoftreatmentwithoutantibiotics AT epponomarjova helisobacterpyloriassociatedgastriculcerdiseaseclinicoimmunologicaleffectivenessoftreatmentwithoutantibiotics AT rakhanferjan helisobacterpyloriassociatedgastriculcerdiseaseclinicoimmunologicaleffectivenessoftreatmentwithoutantibiotics
_version_	1718422505579872256

HELIСOBACTER PYLORI-ASSOCIATED GASTRIC ULCER DISEASE: CLINICO-IMMUNOLOGI-CAL EFFECTIVENESS OF TREATMENT WITHOUT ANTIBIOTICS

Ejemplares similares